Publicacións en colaboración con investigadores/as de Centro Nacional de Microbiología (22)

2019

  1. Antibody responses to chimeric peptides derived from parasite antigens in mice and other animal species

    Molecular Immunology, Vol. 106, pp. 1-11

  2. In-plate recapturing of a dual-tagged recombinant Fasciola antigen (FhLAP) by a monoclonal antibody (US9) prevents nonspecific binding in ELISA

    PLoS ONE, Vol. 14, Núm. 2

2018

  1. Comparison of recombinant cathepsins L1, L2, and L5 as ELISA targets for serodiagnosis of bovine and ovine fascioliasis

    Parasitology Research, Vol. 117, Núm. 5, pp. 1521-1534

2017

  1. Delineating distinct heme-scavenging and -binding functions of domains in MF6p/helminth defense molecule (HDM) proteins from parasitic flatworms

    Journal of Biological Chemistry, Vol. 292, Núm. 21, pp. 8667-8682

  2. Fasciola spp: Mapping of the MF6 epitope and antigenic analysis of the MF6p/HDM family of heme-binding proteins

    PLoS ONE, Vol. 12, Núm. 11

2015

  1. ANISERP: A new serpin from the parasite Anisakis simplex

    Parasites and Vectors, Vol. 8, Núm. 1

2014

  1. The MF6p/FhHDM-1 major antigen secreted by the trematode parasite fasciola hepatica is a heme-binding protein

    Journal of Biological Chemistry, Vol. 289, Núm. 3, pp. 1441-1456

2012

  1. Ani s 1 and Ani s 7 recombinant allergens are able to differentiate distinct Anisakis simplex-associated allergic clinical disorders

    Archives of Dermatological Research, Vol. 304, Núm. 4, pp. 283-288

2011

  1. Development and evaluation of a new lateral flow immunoassay for serodiagnosis of human fasciolosis

    PLoS Neglected Tropical Diseases, Vol. 5, Núm. 11

  2. MISS-Prot: Web server for self/non-self discrimination of protein residue networks in parasites; Theory and experiments in Fasciola peptides and Anisakis allergens

    Molecular BioSystems, Vol. 7, Núm. 6, pp. 1938-1955

  3. Molecular and immunological characterization of Fasciola antigens recognized by the MM3 monoclonal antibody

    Molecular and Biochemical Parasitology, Vol. 179, Núm. 2, pp. 80-90

  4. Using entropy of drug and protein graphs to predict FDA drug-target network: Theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica

    European Journal of Medicinal Chemistry, Vol. 46, Núm. 4, pp. 1074-1094

2010

  1. Diagnosing human anisakiasis: Recombinant Ani s 1 and Ani s 7 allergens versus the UniCAP 100 fluorescence enzyme immunoassay

    Clinical and Vaccine Immunology, Vol. 17, Núm. 4, pp. 496-502

2009

  1. The Anisakis simplex Ani s 7 major allergen as an indicator of true Anisakis infections

    Clinical and Experimental Immunology, Vol. 156, Núm. 3, pp. 471-478

2008

  1. Mesa redonda 8: Distintas aproximaciones al diagnóstico de las enfermedades parasitarias

    Enfermedades Emergentes

  2. Mixed infection, Trichinella spiralis and Trichinella britovi, in a wild boar hunted in the Province of Cáceres (Spain)

    Experimental Parasitology, Vol. 119, Núm. 3, pp. 430-432

  3. Novel sequences and epitopes of diagnostic value derived from the Anisakis simplex Ani s 7 major allergen

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 63, Núm. 2, pp. 219-225

2006

  1. A recombinant enolase from Anisakis simplex is differentially recognized in natural human and mouse experimental infections

    Medical Microbiology and Immunology, Vol. 195, Núm. 1, pp. 1-10

2004

  1. Aplicación de la técnica PCR-RFLP en la identificación de nematodos implicados en la anisakiasis, humana

    Medicina Clinica, Vol. 122, Núm. 18, pp. 686-689

  2. Evaluation of Trichinella spiralis larva group 1 antigens for serodiagnosis of human trichinellosis

    Journal of Clinical Microbiology, Vol. 42, Núm. 9, pp. 4060-4066